Loading...
Revenio Group Oyj
0KFH.L•LSE
Healthcare
Medical - Equipment & Services
£26.53
£-0.89(-3.24%)
Revenio Group Oyj (0KFH.L) Financial Performance & Income Statement Overview
Review Revenio Group Oyj’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
7.17%
↑ 7.17%
Operating Income Growth
-5.10%
↓ 5.10%
Net Income Growth
-3.19%
↓ 3.19%
Operating Cash Flow Growth
120.03%
↑ 120.03%
Operating Margin
25.02%
↑ 25.02%
Gross Margin
57.91%
↑ 57.91%
Net Profit Margin
18.04%
↑ 18.04%
ROE
18.25%
↑ 18.25%
ROIC
21.58%
↑ 21.58%
Revenio Group Oyj (0KFH.L) Income Statement & Financial Overview
Review Revenio Group Oyj's (0KFH.L) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $30.50M | $23.90M | $25.40M | $23.60M |
| Cost of Revenue | $8.80M | $13.80M | $14.80M | $7.00M |
| Gross Profit | $21.70M | $10.10M | $10.60M | $16.60M |
| Gross Profit Ratio | $0.71 | $0.42 | $0.42 | $0.70 |
| R&D Expenses | $0.00 | $2.10M | $2.70M | $3.00M |
| SG&A Expenses | $0.00 | $2.50M | $2.70M | $1.70M |
| Operating Expenses | $12.60M | $4.60M | $5.30M | $11.50M |
| Total Costs & Expenses | $21.40M | $18.40M | $20.10M | $18.50M |
| Interest Income | $0.00 | $0.00 | $200000.00 | $0.00 |
| Interest Expense | $0.00 | $400000.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $1.10M | $1.20M | $1.80M | $1.10M |
| EBITDA | $10.20M | $6.70M | $7.10M | $6.20M |
| EBITDA Ratio | $0.33 | $0.28 | $0.28 | $0.26 |
| Operating Income | $9.10M | $5.50M | $5.30M | $5.10M |
| Operating Income Ratio | $0.30 | $0.23 | $0.21 | $0.22 |
| Other Income/Expenses (Net) | $200000.00 | -$400000.00 | $200000.00 | -$300000.00 |
| Income Before Tax | $9.30M | $5.10M | $5.50M | $4.80M |
| Income Before Tax Ratio | $0.30 | $0.21 | $0.22 | $0.20 |
| Income Tax Expense | $2.70M | $900000.00 | $1.30M | $1.20M |
| Net Income | $6.60M | $4.20M | $4.10M | $3.60M |
| Net Income Ratio | $0.22 | $0.18 | $0.16 | $0.15 |
| EPS | $0.25 | $0.16 | $0.15 | $0.14 |
| Diluted EPS | $0.25 | $0.16 | $0.15 | $0.14 |
| Weighted Avg Shares Outstanding | $26.72M | $26.60M | $26.60M | $26.28M |
| Weighted Avg Shares Outstanding (Diluted) | $26.72M | $26.60M | $26.60M | $26.28M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan